Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) EBT Margin (2016 - 2025)

Traws Pharma (TRAW) has disclosed EBT Margin for 14 consecutive years, with 45.7% as the latest value for Q2 2025.

  • For Q2 2025, EBT Margin rose 21635430.0% year-over-year to 45.7%; the TTM value through Dec 2025 reached 640.68%, up 6235666.0%, while the annual FY2025 figure was 640.68%, 6235666.0% up from the prior year.
  • EBT Margin hit 45.7% in Q2 2025 for Traws Pharma, up from 9128.07% in the prior quarter.
  • Across five years, EBT Margin topped out at 45.7% in Q2 2025 and bottomed at 216400.0% in Q2 2024.
  • Average EBT Margin over 5 years is 19952.94%, with a median of 8538.6% recorded in 2021.
  • Year-over-year, EBT Margin plummeted -20831228bps in 2024 and then soared 21635430bps in 2025.
  • Traws Pharma's EBT Margin stood at 6719.64% in 2021, then tumbled by -52bps to 10239.29% in 2022, then rose by 22bps to 7967.86% in 2023, then decreased by -18bps to 9425.0% in 2024, then soared by 100bps to 45.7% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 45.7%, 9128.07%, and 9425.0% for Q2 2025, Q1 2025, and Q4 2024 respectively.